Security key
14147L108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,924,242
- Total 13F value
- $12,205,032
- Share change
- -998,762
- Put/Call ratio
- 121%
- SEC-reported price per share
- $1.54
- Number of holders
- 47
- Value change
- -$1,956,121
- Number of buys
- 19
- Number of sells
- 22
- Shares outstanding
- 66,404,538
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
47
Top holders
10
CRDF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Cardiff Oncology, Inc. SEC filings
Cardiff Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14147L108
Recent filing periods:
Ownership snapshot
Top reported holders of CRDF - Cardiff Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F
3/4/5
Highest disclosed value: $3,862,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $3.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$3.86M
Artal Group S.A.
$1.65M
RENAISSANCE TECHNOLOGIES LLC
$1.6M
Laurion Capital Management LP
$1.59M
BlackRock Finance, Inc.
$1.48M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,862,000
1,755,656 shares
|
— | 30 Jun 2022 |
| Artal Group S.A. |
13F
Company
|
—
denominator unverified
|
$1,650,000
750,000 shares
|
— | 30 Jun 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$1,601,000
727,616 shares
|
— | 30 Jun 2022 |
| Laurion Capital Management LP |
13F
Company
|
—
denominator unverified
|
$1,589,000
722,100 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$1,478,000
671,967 shares
|
— | 30 Jun 2022 |
| Thomas Adams PhD |
3/4/5
Former Director
|
—
denominator unverified
|
$1,242,462
477,870 shares
|
— | 10 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
47
Shares
7,924,242
Rows available
47
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
54
Q3 2022 holders
47
Holder diff
-7
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend